Literature DB >> 32716523

Medications and addictive substances potentially inducing or attenuating sleep bruxism and/or awake bruxism.

Cees de Baat1,2,3, Merel Verhoeff4, Jari Ahlberg5, Daniele Manfredini6, Ephraim Winocur7, Petra Zweers8, Fred Rozema9,10, Arjan Vissink11, Frank Lobbezoo1,4.   

Abstract

Bruxism is a repetitive jaw-muscle activity characterised by clenching or grinding of the teeth and/or by bracing or thrusting of the mandible. It can occur during sleep, indicated as sleep bruxism, or during wakefulness, indicated as awake bruxism. Exogenous risk indicators of sleep bruxism and/or awake bruxism are, among others, medications and addictive substances, whereas also several medications seem to have the potential to attenuate sleep bruxism and/or awake bruxism. The objective of this study was to present a narrative literature on medications and addictive substances potentially inducing or aggravating sleep bruxism and/or awake bruxism and on medications potentially attenuating sleep bruxism and/or awake bruxism. Literature reviews reporting evidence or indications for sleep bruxism and/or awake bruxism as an adverse effect of several (classes of) medications as well as some addictive substances and literature reviews on medications potentially attenuating sleep bruxism and/or awake bruxism were used as starting point and guidelines to describe the topics mentioned. Additionally, two literature searches were established on PubMed. Three types of bruxism were distinguished: sleep bruxism, awake bruxism and non-specified bruxism. Generally, there are insufficient evidence-based data to draw definite conclusions concerning medications and addictive substances inducing or aggravating sleep bruxism and/or awake bruxism as well as concerning medications attenuating sleep bruxism and/or awake bruxism. There are insufficient evidence-based data to draw definite conclusions concerning medications and addictive substances inducing or aggravating sleep bruxism and/or awake bruxism as well as concerning medications attenuating sleep bruxism and/or awake bruxism.
© 2020 The Authors. Journal of Oral Rehabilitation published by John Wiley & Sons Ltd.

Entities:  

Keywords:  addictive; adverse effect; attenuating effect; awake bruxism; medication; sleep bruxism

Year:  2020        PMID: 32716523     DOI: 10.1111/joor.13061

Source DB:  PubMed          Journal:  J Oral Rehabil        ISSN: 0305-182X            Impact factor:   3.837


  3 in total

Review 1.  Tooth Wear and Tribological Investigations in Dentistry.

Authors:  Ran Wang; Yuanjing Zhu; Chengxin Chen; Yu Han; Hongbo Zhou
Journal:  Appl Bionics Biomech       Date:  2022-06-09       Impact factor: 1.664

2.  Efficacy of botulinum toxin type a in the targeted treatment of sleep bruxism: a double-blind, randomised, placebo-controlled, cross-over study.

Authors:  Belinda Cruse; Thanuja Dharmadasa; Elise White; Callum Hollis; Andrew Evans; Sifat Sharmin; Tomas Kalincik; Lynette Kiers
Journal:  BMJ Neurol Open       Date:  2022-09-05

Review 3.  Oral Health Disorders in Parkinson's Disease: More than Meets the Eye.

Authors:  Manon Auffret; Vincent Meuric; Emile Boyer; Martine Bonnaure-Mallet; Marc Vérin
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.